March 04, 2019
Rose
The drugmaker’s decision to sell a generic version comes with the industry under pressure to do something about rising list prices.
from Health https://ift.tt/2VBshhI
March 04, 2019
Rose
Health, Health - The New York Times
No comments
Related Posts:
Overlooked No More: Barbara Waxman Fiduccia, Reproductive Rights Advocate- How 700 Epidemiologists Are Living Now, and What They Think Is Next
- Sports, Covid and Kids: New Pediatric Guidelines
- Covid 'Long-Haulers' Need Medical Attention, Experts Urge
- All Santa Wants for Christmas Is to Stay Out of Politics
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment